Suppression of NLRP3 inflammasome by oral treatment with sulforaphane alleviates acute gouty inflammation

Abstract

Oral administration of SFN effectively alleviated acute gouty inflammation by suppression of the NLRP3 inflammasome. Our results provide a novel strategy in which oral treatment with SFN may be beneficial in preventing acute attacks of gout.